AIDS
- SULLIVAN EV, Zahr NM, Zhao Q, Pohl KM, et al
Contributions of cerebral white matter hyperintensities, age, and pedal
perception to postural sway in people living with HIV.
AIDS. 2024 Mar 27. doi: 10.1097/QAD.0000000000003894.
- SCHNURE MC, Kasaie P, Dowdy DW, Genberg BL, et al
Forecasting the effect of HIV-targeted interventions on the age distribution of
people living with HIV: a case study from Kenya.
AIDS. 2024 Mar 27. doi: 10.1097/QAD.0000000000003895.
- GIANELLA S, Anderson C, Chaillon A, Wells A, et al
Impact of influenza and pneumococcal vaccines on HIV persistence and immune
dynamics during suppressive antiretroviral therapy.
AIDS. 2024 Mar 25. doi: 10.1097/QAD.0000000000003882.
- WIJSTMA ES, Jongen VW, Boyd A, van den Elshout M, et al
Concordance between daily diary reported PrEP intake and intraerythrocytic
tenofovir diphosphate (TFV-DP) in the Amsterdam PrEP demonstration project.
AIDS. 2024 Mar 21. doi: 10.1097/QAD.0000000000003889.
AIDS Res Hum Retroviruses
- RENRONG T, Li T, Zhang MX, Song TZ, et al
Nonnegligible contribution of non-lymphoid tissue to viral reservoir during the
short-term early cART in SIVmac239-infected Chinese rhesus macaques.
AIDS Res Hum Retroviruses. 2024 Mar 27. doi: 10.1089/AID.2023.0130.
Antimicrob Agents Chemother
- COSSU MV, D'Avolio A, Gervasoni C, Giacomelli A, et al
Switching to deltoid intramuscular injections maintains therapeutic trough
concentrations of rilpivirine and cabotegravir in people with HIV.
Antimicrob Agents Chemother. 2024 Mar 27:e0017524. doi: 10.1128/aac.00175.
- HAN K
Reply to Cossu et al., "Switching to deltoid intramuscular injections maintains
therapeutic trough concentrations of rilpivirine and cabotegravir in people with
HIV".
Antimicrob Agents Chemother. 2024 Mar 27:e0020424. doi: 10.1128/aac.00204.
Cancer
- MEGHANI K, Puri P, Bazzett-Matabele L, Vuylsteke P, et al
Significance of HIV status in cervical cancer patients receiving curative
chemoradiation therapy, definitive radiation alone, or palliative radiation in
Botswana.
Cancer. 2024 Mar 26. doi: 10.1002/cncr.35289.
Clin Infect Dis
- BERTUMEN JB, Pascopella L, Han E, Glenn-Finer R, et al
Epidemiology and Treatment Outcomes of Tuberculosis with Chronic Hepatitis B
Infection-California, 2016-2020.
Clin Infect Dis. 2024 Mar 26:ciae169. doi: 10.1093.
- JAO J, Bonner LB, Dobinda K, Powis KM, et al
Lower Insulin Sensitivity Through 36 Months of Life With in Utero HIV and
Antiretroviral Exposure in Botswana: Results From the Tshilo Dikotla Study.
Clin Infect Dis. 2024 Mar 26:ciae088. doi: 10.1093.
HIV Med
- LIU Y, Cheng Z, Xian Y, Liu X, et al
Cascade analysis of awareness, willingness, uptake and adherence with regard to
PrEP among young men who have sex with men (YMSM) in China: A comparison between
students and non-students.
HIV Med. 2024 Mar 27. doi: 10.1111/hiv.13639.
- OTTAWAY Z, Campbell L, Fox J, Burns F, et al
HIV outcomes during the COVID-19 pandemic in people of Black ethnicities living
with HIV in England.
HIV Med. 2024 Mar 26. doi: 10.1111/hiv.13640.
- SAWRY S, Ayalew K, Maimela G, Briggs-Hagen M, et al
Assessment of weight gain in adult patients living with HIV receiving first-line
dolutegravir-based or efavirenz-based ART regimens in routine care clinics in
Tshwane district, South Africa: An observational study.
HIV Med. 2024 Mar 22. doi: 10.1111/hiv.13638.
J Acquir Immune Defic Syndr
- LINNEMAYR S, Wagner Z, Saya UY, Stecher C, et al
Behavioral economic incentives to support HIV care: Results from a randomized
controlled trial in Uganda.
J Acquir Immune Defic Syndr. 2024 Mar 27. doi: 10.1097/QAI.0000000000003420.
- QIAN Y, Zhang P, Wang L, Suo J, et al
The association of intraocular efavirenz concentrations and HIV-1 viral load
among persons with HIV.
J Acquir Immune Defic Syndr. 2024 Mar 25. doi: 10.1097/QAI.0000000000003426.
- PATEL D, Williams WO, Wright C, Essuon A, et al
CDC-Funded HIV Testing and Undiagnosed HIV Infection in Ending the HIV Epidemic
in the U.S. Jurisdictions.
J Acquir Immune Defic Syndr. 2024 Mar 23. doi: 10.1097/QAI.0000000000003424.
- HICKEY MD, Grochowski J, Mayorga-Munoz F, Oskarsson J, et al
Identifying Implementation Determinants and Strategies for Long-Acting Injectable
Cabotegravir-Rilpivirine in People with HIV Who Are Virally Unsuppressed.
J Acquir Immune Defic Syndr. 2024 Mar 27. doi: 10.1097/QAI.0000000000003421.
J Infect Dis
- OLSSON O, Sokilde R, Tesfaye F, Karlson S, et al
Tuberculosis disease is associated with elevated plasma ribonuclease activity in
antiretroviral treatment-naive people with HIV.
J Infect Dis. 2024 Mar 25:jiae143. doi: 10.1093.
- XIU F, Flores Anato JL, Cox J, Grace D, et al
Characteristics of the Sexual Networks of Men Who Have Sex With Men in Montreal,
Toronto, and Vancouver: Insights from Canada's 2022 Mpox Outbreak.
J Infect Dis. 2024;229.
- SNYDER RE, Saadeh K, Tang EC, Johnson KA, et al
Sexual Exposures Associated With Mpox Infection: California, November 2022 to
June 2023.
J Infect Dis. 2024;229.
J Med Virol
- KASSAM P, El-Zein M, Laurie C, Tota JE, et al
Use of a carrageenan-based gel had no impact on anal HPVs 16 and 18 viral loads
in gay, bisexual, and other men who have sex with men.
J Med Virol. 2024;96:e29562.
- FARAONE JN, Wang X, Qu P, Zheng YM, et al
Neutralizing antibody response to SARS-CoV-2 bivalent mRNA vaccine in
SIV-infected rhesus macaques: Enhanced immunity to XBB subvariants by two-dose
vaccination.
J Med Virol. 2024;96:e29520.
- KIM M, Kim E
Effective vaccination strategies for human papillomavirus (HPV) infection and
cervical cancer based on the mathematical model with a stochastic process.
J Med Virol. 2024;96:e29558.
JAMA
- STOOPLER ET, Villa A, Bindakhil M, Diaz DLO, et al
Common Oral Conditions: A Review.
JAMA. 2024;331:1045-1054.
Lancet
- BEYRER C, Kamarulzaman A, Isbell M, Amon J, et al
Under threat: the International AIDS Society-Lancet Commission on Health and
Human Rights.
Lancet. 2024 Mar 20:S0140-6736(24)00302-7. doi: 10.1016/S0140-6736(24)00302.
Lancet Infect Dis
-
Global, regional, and national age-specific progress towards the 2020 milestones
of the WHO End TB Strategy: a systematic analysis for the Global Burden of
Disease Study 2021.
Lancet Infect Dis. 2024 Mar 19:S1473-3099(24)00007.
- LADHANI SN, White PJ, Campbell H, Mandal S, et al
Use of a meningococcal group B vaccine (4CMenB) in populations at high risk of
gonorrhoea in the UK.
Lancet Infect Dis. 2024 Mar 20:S1473-3099(24)00031.
- NAIDOO K, Perumal R, Cox H, Mathema B, et al
The epidemiology, transmission, diagnosis, and management of drug-resistant
tuberculosis-lessons from the South African experience.
Lancet Infect Dis. 2024 Mar 22:S1473-3099(24)00144.
- CHAKAYA J, Fatma R, Cader M, Harries AD, et al
Post-tuberculosis lung disease: is there a light at the end of tunnel?
Lancet Infect Dis. 2024 Mar 22:S1473-3099(24)00136.
Nat Med
- O'LEARY K
Combination treatment for immune-mediated HIV remission.
Nat Med. 2024 Mar 26. doi: 10.1038/d41591-024-00020.
Pediatr Infect Dis J
- GREYBE L, Barnabas S, Cotton M, Rose P, et al
Cardiometabolic Risk Profiles of Adolescents Living With Perinatally Acquired HIV
in South Africa.
Pediatr Infect Dis J. 2024 Mar 26. doi: 10.1097/INF.0000000000004340.
PLoS One
- SAKOI-MOSETLHI M, Ajibola G, Haghighat R, Batlang O, et al
Caregivers of children with HIV in Botswana prefer monthly IV Broadly
Neutralizing Antibodies (bNAbs) to daily oral ART.
PLoS One. 2024;19:e0299942.
- SINGATA-MADLIKI M, Smit J, Beksinska M, Balakrishna Y, et al
Effects of injectable contraception with depot medroxyprogesterone acetate or
norethisterone enanthate on estradiol levels and menstrual, psychological and
behavioral measures relevant to HIV risk: The WHICH randomized trial.
PLoS One. 2024;19:e0295764.
-
Expression of Concern: Evidence that Vpu Modulates HIV-1 Gag-Envelope Interaction
towards Envelope Incorporation and Infectivity in a Cell Type Dependent Manner.
PLoS One. 2024;19:e0301303.
- AHMADPOUR E, Valilou S, Ghanizadegan MA, Seyfi R, et al
Global prevalence, mortality, and main characteristics of HIV-associated
pneumocystosis: A systematic review and meta-analysis.
PLoS One. 2024;19:e0297619.
- OWUSU M, Adu E, Kalu LE, Martey E, et al
Aetiological agents of pneumonia among HIV and non-HIV infected children in
Ghana: A case-control study.
PLoS One. 2024;19:e0299222.
- AGIMAS MC, Solomon M, Shewaye DA, Abebaw Angaw D, et al
Prevalence of delayed treatment for sexually transmitted infections and its
determinants in sub-Saharan Africa. A systematic review and meta-analysis.
PLoS One. 2024;19:e0299629.
- VECHI HT, Bay MB, Freitas CHS, Sant'anna JGFC, et al
Factors associated with hepatitis A susceptibility among men who have sex with
men using HIV pre-exposure prophylaxis in Northeastern Brazil: A cross-sectional
study.
PLoS One. 2024;19:e0301397.
Science
- COHEN J
Africa may lead rollout of long-lasting HIV drug.
Science. 2024;383:1403.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016